No telehealth services are confirmed to still safely offer compounded GLP-1s after the FDA’s March and June 2026 crackdowns; major platforms have either stopped offering them entirely or transitioned exclusively to FDA-approved alternatives like Wegovy, Zepbound, and Saxenda [3]. The FDA has issued over 100 warning letters across three enforcement waves (February, March, and June 2026) to telehealth firms for promoting compounded GLP-1s with false or misleading claims, explicitly stating these products lack proven safety, efficacy, or consistent quality [1][2][5]. High-profile companies that previously offered compounded versions have exited the model: Company Status After Crackdown Hims & Hers Exited compounded semaglutide entirely in March 2026; now an authorized distributor of branded Wegovy and Ozempic [3][10] Ro Stopped compounded GLP-1s; now offers Wegovy and Zepbound [3] Good Life Eliminated compounded offerings; focuses on FDA-approved alternatives [3] Medica Weight Loss, Ready Med, Clover Meds Received June 2026 warning letters; compliance status unclear but likely halted or under review [1] Beluga Health, OpenLoop, MD Integrations Affiliations warned; at least 30% of warned companies linked to these groups, suggesting widespread cessation [6] The post-crackdown landscape is shifting to a manufacturer-centric distribution network, where Novo Nordisk and Eli Lilly offer direct-to-telehealth programs bundling FDA-approved drugs with adherence kits and reimbursement interfaces [2]. If you are seeking weight-loss treatment, the safest and most reliable options are currently: Wegovy (Novo Nordisk) – FDA-approved for chronic weight management [3] Zepbound (Eli Lilly) – FDA-approved for weight loss [3] Saxenda (Novo Nordisk) – FDA-approved, often used with generics [3] For access, consult licensed telehealth platforms that now focus on approved medications, such as Ro and Hims & Hers [3]. Compounded GLP-1s remain legally permissible only in rare cases (e.g., specific allergies or unavailable dosages), but mainstream telehealth platforms have largely eliminated them [3][12].
Mentioned in position 6 of 11
Read full answer with sources →